https://de.marketscreener.com/kurs/aktie/RELIEF-THERAPEUTICS-HOLDI-5527488/news/EQS-News-Relief-und-AdVita-verkunden-Beginn-der-Phase-2-Studie-mit-inhalativer-33031684/?utm_source=telegram&utm_medium=social&utm_campaign=share